BRC News

In the 2024 to 2025 reporting year, UCLH recruited the first participant in the UK in 10 commercial trials, the first participant in Europe on four occasions, and the first globally in two commercial trials.

The world-first pilot project run by researchers at UCL and King’s College London is supported by the BRC.

Newly reported updated results of a study from UCLH and UCL highlights the powerful benefits of a targeted immune therapy for a type of slow-growing blood cancer.

The service is enabling patients to access targeted treatments they desperately need.

The personalised therapy is for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia.

Myotonic Dystrophy Type 1 (DM1) is a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.

A team of researchers at UCL and UCLH have identified the key brain regions that are essential for logical thinking and problem solving.

The BRC-supported research project will monitor infections such as Covid-19, flu and norovirus.

The collaboration between UCLH and Roche Pharmaceuticals aimed to identify barriers for which practical and actionable solutions could be found.

The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

UCLH has recruited its first patient in a national study looking at whether continuous glucose monitoring can improve pregnancy outcomes for women with early-onset type 2 diabetes.

The UK national screening programme begins from 1 April 2025.

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery.

The parts of the brain that are needed to remember words, and how these are affected by a common form of epilepsy, have been identified by a team of neurologists and neurosurgeons at UCL.

A number of BRC-supported researchers have been appointed or re-appointed as National Institute for Health and Care Research Senior Investigators in the NIHR’s 2025 round of awards.